Cell Biology · Provider Reference

What Is Wharton's Jelly?

The gelatinous connective tissue inside the umbilical cord — and the specific source most cord-derived MSC products are referring to.

Anatomy and Composition

Wharton's jelly is the mucous connective tissue that fills the space within the umbilical cord, surrounding and protecting the umbilical arteries and vein. It's named for Thomas Wharton, the 17th-century anatomist who first described it. Structurally, it's a hydrated extracellular matrix composed largely of hyaluronic acid, collagen, and proteoglycans — a gel-like scaffold rather than a cellular tissue in the conventional sense, though it houses the mesenchymal stromal cells most cord-tissue products are derived from.

Not the Same as Cord Blood

Wharton's jelly is frequently confused with cord blood, but they're distinct tissues with different cell content:

  • Cord blood — the blood remaining in the cord and placenta after birth; primarily a source of hematopoietic stem cells, historically used for treating blood and immune disorders.
  • Wharton's jelly — the connective tissue matrix of the cord itself; the primary source of umbilical cord-derived mesenchymal stem cells.

A product described as "umbilical cord-derived" should specify which tissue component it's sourced from, since the two contain functionally different cell populations.

Why It's Used as an MSC Source

Wharton's jelly-derived MSCs are collected from donor tissue at birth — avoiding the age-related decline in proliferation capacity seen in adult tissue sources — and the collection process is non-invasive to the donor, since the tissue is recovered after a healthy birth from tissue that would otherwise be discarded. See Umbilical Cord vs. Bone Marrow Stem Cells for a fuller comparison against other sources.

This page is educational reference material for licensed healthcare providers and does not constitute medical, legal, or regulatory advice. HCT/P products are not FDA-approved.